Estrebillo, Lea .

HRN: 28-90-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2026
METRONIDAZOLE 500MG (TAB)
04/28/2026
05/05/2026
PO
500mg
TID
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: